BioCentury | Jan 11, 2016
Financial News

Pathway Genomics completes venture financing

Pathway Genomics Corp. , San Diego, Calif. Business: Diagnostic Date completed: 2016-01-05 Type: Venture financing Raised: $40 million Investors: IBM Watson; and other undisclosed investors Note: Pathway said it raised more than $40 million in the...
BioCentury | Jan 6, 2016
Financial News

Pathway Genomics raises $40M

Pathway Genomics Corp. (San Diego, Calif.) said it raised more than $40 million in a series E round from investors including the IBM Watson unit of IBM Corp. (NYSE: IBM). Pathway said it expects to...
BioCentury | Sep 28, 2015
Company News

Pathway Genomics sales and marketing update

...in nine cancer genes. The test costs $299 and is performed in Pathway’s CLIA-certified lab. Pathway Genomics Corp....
BioCentury | Aug 3, 2015
Company News

Pathway Genomics sales and marketing update

...and BRCA2 mutations in the patient population. The list price for the test is $399. Pathway Genomics Corp....
BioCentury | May 4, 2015
Company News

Pathway Genomics sales and marketing update

...in 15 genes associated with colorectal cancer. LynchSyndromeTrue tests five genes associated with Lynch syndrome. Pathway Genomics Corp....
BioCentury | Feb 16, 2015
Company News

Myriad Genetics, Quest Diagnostics diagnostic news

...BRCA2 mutations. Last month, Myriad reached similar settlements with Invitae Corp. (San Francisco, Calif.) and Pathway Genomics Corp....
BioCentury | Feb 9, 2015
Company News

Invitae, Myriad Genetics, Pathway Genomics diagnostic news

...2014). Invitae Corp. , San Francisco, Calif. Myriad Genetics Inc. (NASDAQ:MYGN), Salt Lake City, Utah Pathway Genomics Corp....
BioCentury | Oct 20, 2014
Company News

Pathway Genomics sales and marketing update

...partner and localizer of BRCA2 (PALB2) genes. The company could not be reached for details. Pathway Genomics Corp....
BioCentury | Jun 23, 2014
Company News

Myriad Genetics Inc, Pathway Genomics diagnostic news

...10, 2014 & March 17, 2014). Myriad Genetics Inc . (NASDAQ:MYGN), Salt Lake City, Utah Pathway Genomics Corp....
BioCentury | Jun 9, 2014
Company News

Pathway Genomics Corp. sales and marketing update

...sequencing and deletion/duplication analysis assay that can detect mutations in the BRCA1 and BRCA2 genes. Pathway Genomics...
...the One for One program, for every BRCATrue test sold that is covered by insurance, Pathway Genomics...
...to $40,000 in tests per month and up to $10 million in tests in aggregate. Pathway Genomics Corp....
Items per page:
1 - 10 of 32
BioCentury | Jan 11, 2016
Financial News

Pathway Genomics completes venture financing

Pathway Genomics Corp. , San Diego, Calif. Business: Diagnostic Date completed: 2016-01-05 Type: Venture financing Raised: $40 million Investors: IBM Watson; and other undisclosed investors Note: Pathway said it raised more than $40 million in the...
BioCentury | Jan 6, 2016
Financial News

Pathway Genomics raises $40M

Pathway Genomics Corp. (San Diego, Calif.) said it raised more than $40 million in a series E round from investors including the IBM Watson unit of IBM Corp. (NYSE: IBM). Pathway said it expects to...
BioCentury | Sep 28, 2015
Company News

Pathway Genomics sales and marketing update

...in nine cancer genes. The test costs $299 and is performed in Pathway’s CLIA-certified lab. Pathway Genomics Corp....
BioCentury | Aug 3, 2015
Company News

Pathway Genomics sales and marketing update

...and BRCA2 mutations in the patient population. The list price for the test is $399. Pathway Genomics Corp....
BioCentury | May 4, 2015
Company News

Pathway Genomics sales and marketing update

...in 15 genes associated with colorectal cancer. LynchSyndromeTrue tests five genes associated with Lynch syndrome. Pathway Genomics Corp....
BioCentury | Feb 16, 2015
Company News

Myriad Genetics, Quest Diagnostics diagnostic news

...BRCA2 mutations. Last month, Myriad reached similar settlements with Invitae Corp. (San Francisco, Calif.) and Pathway Genomics Corp....
BioCentury | Feb 9, 2015
Company News

Invitae, Myriad Genetics, Pathway Genomics diagnostic news

...2014). Invitae Corp. , San Francisco, Calif. Myriad Genetics Inc. (NASDAQ:MYGN), Salt Lake City, Utah Pathway Genomics Corp....
BioCentury | Oct 20, 2014
Company News

Pathway Genomics sales and marketing update

...partner and localizer of BRCA2 (PALB2) genes. The company could not be reached for details. Pathway Genomics Corp....
BioCentury | Jun 23, 2014
Company News

Myriad Genetics Inc, Pathway Genomics diagnostic news

...10, 2014 & March 17, 2014). Myriad Genetics Inc . (NASDAQ:MYGN), Salt Lake City, Utah Pathway Genomics Corp....
BioCentury | Jun 9, 2014
Company News

Pathway Genomics Corp. sales and marketing update

...sequencing and deletion/duplication analysis assay that can detect mutations in the BRCA1 and BRCA2 genes. Pathway Genomics...
...the One for One program, for every BRCATrue test sold that is covered by insurance, Pathway Genomics...
...to $40,000 in tests per month and up to $10 million in tests in aggregate. Pathway Genomics Corp....
Items per page:
1 - 10 of 32